Edit |   |
---|---|
Antigenic Specificity | ANGPT2 & VEGFA, Human, (Vanucizumab biosimilar) |
Clone | Vanucizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | VH-C kappa-CH2-CH3_V lambda-CH1_H-GAMMA-1_l kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | WB, FCM, IP, ELISA, Neut, FuncS, IF |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human ANGPT2 & VEGFA Recombinant Antibody (Vanucizumab). Vanucizumab (INN, development code RG7221) is an experimental humanized monoclonal antibody designed for the treatment of cancer. |
Immunogen | n/a |
Other Names | Anti-ANGPT2 & VEGFA Recombinant Antibody, Research Grade Vanucizumab, Anti-Human ANGPT2 & VEGFA Recombinant Antibody(Vanucizumab), RG-7221, RG7221, RO5520985, Antibody Drug Analogues, Monoclonal Antibody, YR1341, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1448221-05-3 |
Catalog # | YR1341 |
Price | please inquire |
Order / More Info | ANGPT2 & VEGFA, Human, (Vanucizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |